Baxter buys stake in Ocular Therapeutix June 10, 2013 By Brad Perriello Baxter‘s (NYSE:BAX) venture capital arm bought a minority stake in Ocular Therapeutix and its slate of ophthalmic products, part of an $8.5 million funding round that also included existing backer Ascension Health Ventures.
